Avacta Group PLC
LSE:AVCT

Watchlist Manager
Avacta Group PLC Logo
Avacta Group PLC
LSE:AVCT
Watchlist
Price: 50.7 GBX 0.4% Market Closed
Market Cap: 181.9m GBX
Have any thoughts about
Avacta Group PLC?
Write Note

Relative Value

The Relative Value of one AVCT stock under the Base Case scenario is 128.91 GBX. Compared to the current market price of 50.7 GBX, Avacta Group PLC is Undervalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AVCT Relative Value
Base Case
128.91 GBX
Undervaluation 61%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
79
vs Industry
43
Median 3Y
30.6
Median 5Y
40.6
Industry
8.1
Forward
7.4
vs History
vs Industry
Median 3Y
-9.2
Median 5Y
-11.1
Industry
23
Forward
-5.1
vs History
vs Industry
Median 3Y
-17.7
Median 5Y
-18
Industry
23.4
vs History
vs Industry
10
Median 3Y
-8.4
Median 5Y
-14.4
Industry
27.3
vs History
84
vs Industry
7
Median 3Y
7.5
Median 5Y
7.3
Industry
2.6
vs History
79
vs Industry
35
Median 3Y
32.2
Median 5Y
39.8
Industry
8.1
Forward
7.2
vs History
69
vs Industry
22
Median 3Y
35.9
Median 5Y
45
Industry
9.6
vs History
vs Industry
Median 3Y
-11.3
Median 5Y
-13
Industry
4.3
Forward
-6.9
vs History
vs Industry
Median 3Y
-10.2
Median 5Y
-11.5
Industry
3.8
Forward
-5.2
vs History
vs Industry
Median 3Y
-17
Median 5Y
-18.1
Industry
6
vs History
vs Industry
Median 3Y
-16.1
Median 5Y
-16.2
Industry
3.8
vs History
79
vs Industry
29
Median 3Y
7.6
Median 5Y
9.5
Industry
4.8

Multiples Across Competitors

AVCT Competitors Multiples
Avacta Group PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Avacta Group PLC
LSE:AVCT
183.1m GBP 8.1 -7.1 -5.9 -5.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 380 957.8 -177 666.1 -215 743.3 -213 281.4
US
Abbvie Inc
NYSE:ABBV
302.3B USD 5.4 59.5 14.9 22.9
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 4.9 38 17.7 33.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD 11.9 -263.2 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
117.6B USD 4.2 933 10.4 10.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 884.6 -480.9 -523.7 -509.7
AU
CSL Ltd
ASX:CSL
138.5B AUD 6.1 34.3 21.1 26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 6.5 19.4 17.9 19.9
US
Seagen Inc
F:SGT
39.3B EUR 18.2 -55.7 -59.8 -54
NL
argenx SE
XBRU:ARGX
33.4B EUR 18.2 -127.9 -102.8 -74.9
P/E Multiple
Earnings Growth
UK
Avacta Group PLC
LSE:AVCT
Average P/E: 216.8
Negative Multiple: -7.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -177 666.1 N/A
US
Abbvie Inc
NYSE:ABBV
59.5
412%
US
Amgen Inc
NASDAQ:AMGN
38
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.2
42%
US
Gilead Sciences Inc
NASDAQ:GILD
933
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -480.9 N/A
AU
CSL Ltd
ASX:CSL
34.3
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -127.9 N/A
EV/EBITDA Multiple
EBITDA Growth
UK
Avacta Group PLC
LSE:AVCT
Average EV/EBITDA: 18.1
Negative Multiple: -5.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 743.3 N/A
US
Abbvie Inc
NYSE:ABBV
14.9
28%
US
Amgen Inc
NASDAQ:AMGN
17.7
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523.7 N/A
AU
CSL Ltd
ASX:CSL
21.1
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -102.8 N/A
EV/EBIT Multiple
EBIT Growth
UK
Avacta Group PLC
LSE:AVCT
Average EV/EBIT: 23.5
Negative Multiple: -5.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -213 281.4 N/A
US
Abbvie Inc
NYSE:ABBV
22.9
88%
US
Amgen Inc
NASDAQ:AMGN
33.4
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -509.7 N/A
AU
CSL Ltd
ASX:CSL
26.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -74.9 N/A

See Also

Discover More
Back to Top